The Alfred Hospital, Monash University
Welcome,         Profile    Billing    Logout  
 11 Trials 
14 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Snell, Greg I
TFF-T2-001, NCT05501574: An Open Label Trial Evaluating the Safety, Tolerability, Efficacy and Pharmacokinetic Profile of Tacrolimus Inhalation Powder in Adult Lung Transplant Recipients

Terminated
2
14
RoW
Tacrolimus Inhalation Powder, Tacrolimus, Plastiape RS00 Dry Powder inhaler device
TFF Pharmaceuticals, Inc., Novotech (Australia) Pty Limited
Lung Transplant Rejection
10/24
12/24
INTERLUNG, NCT02812290: Diagnostic and Therapeutic Applications of Microarrays in Lung Transplantation

Recruiting
N/A
700
Europe, Canada, US, RoW
Lung transplant biopsy bites.
University of Alberta
Lung Transplant Rejection
11/25
06/26
NCT05837663: Trifecta-Lung cfDNA-MMDx Study

Recruiting
N/A
600
Europe, Canada, US, RoW
University of Alberta, Natera, Inc., One Lambda
Lung Transplantation
11/26
12/27
Hachem, Ramsey
NCT05654922: Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant

Recruiting
3
100
US
ARINA-1, Standard of care only
Renovion, Inc.
Pre-Bronchiolitis Obliterans Syndrome
01/25
06/25
BOSTON-2, NCT03656926 / 2018-003205-25: Efficacy + Safety of Liposome Cyclosporine a to Treat Bronchiolitis Obliterans Post Single Lung Transplant

Completed
3
220
Europe, US, RoW
Liposomal Cyclosporine A, L-CsA, Standard of Care, SoC
Zambon SpA, BREATH Therapeutics Inc.
Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection, Lung Transplant; Complications, Lung Transplant Failure and Rejection, Chronic Lung Allograft Dysfunction
03/24
03/24
BOSTON-1, NCT03657342 / 2018-003204-39: Efficacy + Safety of Liposome Cyclosporine a to Treat Bronchiolitis Obliterans Post Single Lung Transplant

Completed
3
220
Europe, US, RoW
Liposomal Cyclosporine A, L-CsA, standard of care, SoC
Zambon SpA, BREATH Therapeutics Inc.
Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection, Lung Transplant; Complications, Lung Transplant Failure and Rejection, Chronic Lung Allograft Dysfunction
04/24
04/24
ALL IN LUNG, NCT06033196: Tocilizumab in Lung Transplantation

Recruiting
2
350
Canada, US
Tocilizumab, ACTEMRA, Placebo for Tocilizumab
National Institute of Allergy and Infectious Diseases (NIAID)
Lung Transplant
01/29
01/29
INTERLUNG, NCT02812290: Diagnostic and Therapeutic Applications of Microarrays in Lung Transplantation

Recruiting
N/A
700
Europe, Canada, US, RoW
Lung transplant biopsy bites.
University of Alberta
Lung Transplant Rejection
11/25
06/26
Grazia, Todd
NCT05654922: Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant

Recruiting
3
100
US
ARINA-1, Standard of care only
Renovion, Inc.
Pre-Bronchiolitis Obliterans Syndrome
01/25
06/25
NCT05837663: Trifecta-Lung cfDNA-MMDx Study

Recruiting
N/A
600
Europe, Canada, US, RoW
University of Alberta, Natera, Inc., One Lambda
Lung Transplantation
11/26
12/27
Westall, Glen
INTERLUNG, NCT02812290: Diagnostic and Therapeutic Applications of Microarrays in Lung Transplantation

Recruiting
N/A
700
Europe, Canada, US, RoW
Lung transplant biopsy bites.
University of Alberta
Lung Transplant Rejection
11/25
06/26
NCT05837663: Trifecta-Lung cfDNA-MMDx Study

Recruiting
N/A
600
Europe, Canada, US, RoW
University of Alberta, Natera, Inc., One Lambda
Lung Transplantation
11/26
12/27
Eagan, Christina
SAPPHIRE, NCT03814317: Inhaled Treprostinil in Sarcoidosis Patients With Pulmonary Hypertension

Recruiting
2
10
US
Inhaled Treprostinil, Tyvaso®, pulmonary arterial hypertension (PAH) therapy
University of Florida, United Therapeutics
Sarcoidosis, Precapillary Pulmonary Hypertension, Interstitial Lung Disease
01/25
07/25
NCT05837663: Trifecta-Lung cfDNA-MMDx Study

Recruiting
N/A
600
Europe, Canada, US, RoW
University of Alberta, Natera, Inc., One Lambda
Lung Transplantation
11/26
12/27

Download Options